Our work

Explore the case studies showing BioPacific’s work with Australian and New Zealand life science venture over the years. 

Governance advisory for an early stage Agritech venture

The early-stage agritech company was faced with the challenge of managing conflict between the board and shareholders. The founders engaged BioPacific Partners to deliver governance advice to unify the board and provide stability while also protecting the interests of the founders. BioPacific also assisted the company in preparation for their subsequent capital raise by setting up milestones, scoping and engaging with investors, and providing ongoing support to close the funding round.

From bench top to bedside

BioPacific worked with a renowned public research institute in bringing their novel pharmaceutical drug to the market. The challenge was to conduct due diligence on the scientific asset and understand its weakness and opportunity to produce an effective commercial strategy to bring the product to the market. In doing so, BioPacific identified a niche value chain for the product while also assessing potential collaborators.

Establishing a botanical drug company

BioPacific Partners helped an innovator to establish a botanical drug company. This included mentoring the CEO on commercialisation strategy, organisational governance, and preparing the company for fundraising. As a result the venture was able to raise an investment of $600,000 seed funding from angel investors. BioPacific continues to work with the venture, assisting with initial recruitments and preparing for the next fundraise as the product approaches FDA approval.

Bioenergy study for government: Wood Fibre Futures

BioPacific Partners was commissioned in 2020 by a government department to deliver a global technology scan. Our team led a consortium of local and international experts to identify investment opportunities for the use of forest biomass to achieve the government’s goal of a carbon-zero future. The project involved the publication of a 125-page industry report which discussed short-term (5-10 years) and long-term (20-30 years) investment options. BioPacific ranked each potential opportunity that warranted further action and provided recommendations on how to execute the opportunities successfully.

Unleashing the potential of platform technology

BioPacific Partners helped a publicly-listed Medtech company to identify new areas of application for their novel medical technology. The technology initially focused on sports and performance, however, BioPacific was able to identify 13 new areas of application. Further discussion and prioritisation resulted in the company focusing on two of the recommended sectors and initiating development plans to enter these markets. As a result of this expansion, the company has since tripled in value.

Value-growth for smart beverage

BioPacific worked closely in the growth stages of a functional beverage company as they were positioning themselves to enter the market. BioPacific helped create a road-map value growth strategy, prepare the company for financial due-diligence, and to develop targets for subsequent fundraises.  Our team worked with the founders to prepare for their upcoming capital raise by strategising critical milestones and setting down multi-phase plans that were underpinned by the incoming investment. The company was able to successfully raise $2.8 million and is currently expanding into international markets.

Establishing the University’s investment framework

With an increasing focus on research commercialisation, a top-100 life sciences university sought BioPacific Partners’ expertise to help them establish a decision-making framework for capital investment. We led the committee-based decision-making process which enabled a high degree of buy-in from the university and academics. This framework was then successfully established as a multi-year program which enable the university to invest in innovative research with commercial value.

Refocusing governance and capabilities

BioPacific Partners was approached by a publicly-listed MedTech company to help refocus and strengthen the business’ core value proposition. Our team helped identify and terminate distracting programs which allowed for a renewed focus and emphasis on the technology’s unique value proposition. We further assisted the company in strengthening their supply chain and establishing pilot manufacturing capabilities. In addition to this, BioPacific Partners helped to further strengthen and streamline the board’s structure and functionality.

Unleashing the potential of a manufacturing technology

BioPacific Partners assisted a large med-tech manufacturing firm to explore additional applications of their novel manufacturing technology. In doing so, the team at BioPacific brainstormed and conducted extensive options research to produce more than 30 different potential areas to explore. In conjunction with the client, our team were able to strategically prioritise and focus on 8 opportunities. A deeper dive into the 8 opportunities was presented to the client, along with advice on financing these additional efforts.